Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
CROSS
1 other identifier
observational
300
8 countries
18
Brief Summary
The objective of this prospective, international cohort is to incorporate the low stable pressure (using Airseal Insufflator) approach and its associated parameters into the early rehabilitation program after colorectal surgery so as to shorten hospitalization up to the ambulatory care and reduce postoperative pain and opioid consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2023
CompletedFirst Posted
Study publicly available on registry
December 4, 2023
CompletedStudy Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedAugust 1, 2025
July 1, 2025
1.7 years
November 24, 2023
July 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the impact of the stable low-pressure approach (using Airseal Insufflator) and its associated parameters into the the early rehabilitation program after colorectal surgery on length of stay.
Evaluate the Length of hospital stay after colorectal surgery.
From the surgery to the end of the hospitalization (max 30 days)
Secondary Outcomes (6)
The impact of stable low pressure on the postoperative pain after colorectal surgery
At 24 hours after the end of the surgery
The impact of stable low pressure on the opioid consumption after colorectal surgery
From the surgery to the end of the hospitalization (max 30 days)
The impact of the different mini-invasive approaches on the feasibility and benefit of low stable pressure
From the surgery to the end of the hospitalization (max 30 days)
The Post-operative Surgical and Medical morbidity
From the surgery to the end of the hospitalization (max 30 days)
The impact of the anesthetic management on the feasibility and benefit of low stable pressure
From the surgery to the end of the hospitalization (max 30 days)
- +1 more secondary outcomes
Study Arms (1)
International cohort
This is an international cohort (France and other international centers) which consists of including patients undergoing colorectal surgery performed at low pressure for benign or malignant pathology.This stage 2b cohort study is a pilot study assessing the best operative association with stable low-pressure pneumoperitoneum in order to optimize postoperative outcomes after mini invasive colorectal surgery.
Eligibility Criteria
This cohort study is a pilot study assessing the best operative association with stable low-pressure pneumoperitoneum in order to optimize postoperative outcomes after mini-invasive colorectal surgery. The use of robotic or microsurgical instrumentation, neuromuscular blockade, patient positioning, pre-stretching of the abdominal wall and ventilation-parameters could not be separately tested in randomized trial. In this pilot study, we aim to include 300 patients with low stable pneumoperitoneum with Colorectal surgery. All patient assessements will be done according to the sites standard of care.
You may qualify if:
- Age ≥ 18 years old
- Colonic resection (right or left, subtotal or total) performed for benign or malignant pathology
- Rectal resection with or without stoma for benign or malignant pathology
- Laparoscopic or robotic procedure
- Surgery under low stable pressure pneumoperitoneum with AirSeal
- Patient who benefits by medicare system
- Oral agreement after reading information letter
You may not qualify if:
- Laparotomy procedure
- Associated resection (except appendectomy or liver biopsy)
- Transverse colectomy
- Emergency procedure
- Pelvic sepsis
- Pregnancy or breast feeding period
- Legal incapacity or physical, psychological social or geographical status interfering with the patient's ability to agree to participate in the study
- Persons deprived of liberty or under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (18)
Universitair Ziekenhuis
Jette, Brussels Capital, 1090, Belgium
Hôpital Jean Minoz
Besançon, 25030, France
Clinique Tivoli-Ducos - Bordeaux Colorectal Institute
Bordeaux, 33 000, France
Hôpital Albert Michallon
La Tronche, 38700, France
Hôpital Bicêtre
Le Kremlin-Bicêtre, 94270, France
Hôpital Nord-Marseille
Marseille, 13915, France
Clinique Hartmann
Neuilly-sur-Seine, 92200, France
Hopital Saint-Louis
Paris, 75010, France
Hôpital Saint-Antoine
Paris, 75012, France
Hôpital Européen Georges Pompidou
Paris, 75908, France
Hôpital Lyon Sud
Pierre-Bénite, 69495, France
Hopital Charles Nicolle
Rouen, 76031, France
St. Georg Klinikum Eisenach
Eisenach, 99817, Germany
Division of Colon and Rectal Surgery
Milan, 20089, Italy
Academic Medical Center
Amsterdam, 1105 AZ, Netherlands
Hospital General Universitario Gregorio
Madrid, 28007, Spain
Hôpitaux Universitaires de Genève
Geneva, 1205, Switzerland
Nhs Fundation Trust
Manchester, M139WL, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Hélène HMM MAILLOU-MARTINAUD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2023
First Posted
December 4, 2023
Study Start
December 15, 2023
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
August 1, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
There are no plans to share individual participant data (IPD) with other researchers